Contact Us
|
Client Login
PRODUCTS & SERVICES
Antibody Products
Antibody Products Store
Neuroscience
Epitope Tags
Structural Proteins & Cell Components
Signal Transduction
Immunopathology
Detection Chemistries & Ancillaries
Custom Immunology Services
Clinical Services
Bioanalytical
Central Laboratory
Clinical Development (Phase I-III)
Discovery & Translational Services
Antibody Products
Biomarker Center of Excellence
BioPathways
Computational Biology
Discovery
Genomics Laboratory
Immunology
Vaccines & Infectious Disease
Nonclinical Services
Antibody Products
Bioanalytical Services
Discovery
Drug Metabolism & Pharmacokinetics
Immunology
Radiosynthesis
Research Models
Safety Pharmacology
Toxicology
Vaccines & Infectious Disease
Biopharmaceutical CMC Solutions
Biorepository Services
Environmental Sciences
Genomics Laboratory
Integration in Drug Development
Market Access
Nutritional Chemistry & Food Safety
Secure Data Access
Strategic Partnering
CAREERS
Search Jobs
College / University
Featured Jobs
Diversity
Benefits
现在就加入科文斯
STUDY PARTICIPANTS
INVESTORS
Investor Information
Investor Home
Stock Information
Board of Directors
Corporate Governance Guidelines
Analyst Coverage
Investor FAQ
Presentations & Webcasts
Financial Information
SEC Filings
Annual Reports
Press Releases
Calendar of Events
Request Information
NEWS
Press Releases
Media Relations
ABOUT COVANCE
Company Overview
Global Locations
Corporate Responsibility
Business Integrity Program
Animal Welfare
Covance.Asia
RESOURCE CENTER
Blog
Investors
Investor Information
Financial Information
SEC Filings
Annual Reports
Press Releases
Calendar of Events
Request Information
Home
> Investors >
Financial Information
>
Press Releases
Financial Information
Press Releases
2004
|
2005
|
2006
|
2007
|
2008
|
2009
|
2010
|
2011
|
2012
|
2013
Date
Title
18-Dec-2008
Covance Updates 2008 Financial Targets and Provides 2009 Guidance
Print
16-Dec-2008
Covance Purchases Equity Stake in Caprion Proteomics
Print
22-Oct-2008
Covance Reports 3Q08 Earnings of $0.80 Per Share
Print
03-Oct-2008
Covance and Lilly Finalize 10-Year, $1.6 Billion Strategic R&D Collaboration
Print
29-Sep-2008
Covance Decides to Pursue Its Original Preclinical Strategy in China
Print
06-Aug-2008
Covance and Lilly Enter Into a Strategic R&D Collaboration
Print
31-Jul-2008
Covance Recognized for Outstanding Performance by Merck & Co., Inc.
Print
31-Jul-2008
Covance Recognized for Outstanding Customer Service by Eli Lilly and Company
Print
30-Jul-2008
Covance Reports 2Q08 Earnings Growth of 22.7% to $0.79 Per Share
Print
24-Jun-2008
Covance and WuXi PharmaTech to Form a Joint Venture to Provide World-Class Preclinical Services in China
Print
16-Jun-2008
Covance Opens Top-Tier Research Clinic In Evansville, Indiana
Print
08-May-2008
Covance Elects Joseph C. Scodari to Company's Board of Directors
Print
05-May-2008
Covance Wins "Best CRO" Award for Supporting Global Vaccine Development
Print
28-Apr-2008
Covance Reports 1Q08 Earnings Growth of 22.3% to $0.73 Per Share
Print
30-Jan-2008
Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
Print
Home
|
Animal Welfare
|
Privacy Policy
|
Contact Us
|
Site Map
|
Investigators
|
Covance.Asia
RSS
© Copyright 2013 Covance Inc. All rights reserved.